Phase II Randomized Pilot Comparing HDR and LDR Monotherapy for Intermediate Risk Prostate Cancer: Report of Dose Escalation to Dominant Intraprostatic Lesions

Publication date: July–August 2018
Source:Brachytherapy, Volume 17, Issue 4, Supplement
Author(s): Steven Tisseverasinghe, Juanita Crook, Brenda Farnquist, Cynthia Araujo, Deidre Batchelar, Michelle Hilts, Francois Bachand




https://ift.tt/2tw4Cnb